Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transthyretin: Its function and amyloid formation.

Neurochemistry international - 1 May 2022

Ueda Mitsuharu

Abstract excerpt

Transthyretin (TTR), which is one of the major amyloidogenic proteins in systemic amyloidosis, forms extracellular amyloid deposits in the systemic organs such as nerves, ligaments, heart, and arterioles, and causes two kinds of systemic amyloidosis, hereditary ATTR (ATTRv) amyloidosis induced by variant TTR and aging-related wild-type ATTR (ATTRwt) amyloidosis. More than 150 different mutations, most of which...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyloid
Share to Amyloidogenic Proteins
Share to Amyloidosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Prealbumin

Source

Identifiers

PMID: 35218869
DOI: 10.1016/j.neuint.2022.105313

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transthyretin: Its function and amyloid formation.PMID 35218869Read ↗

Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.Semantic proximity Read ↗

Transthyretin mutagenesis: impact on amyloidogenesis and disease.Semantic proximity Read ↗

Review: TTR amyloidosis-structural features leading to protein aggregation and their implications on therapeutic strategies.Semantic proximity Read ↗

Hereditary transthyretin amyloidosis overview.Semantic proximity Read ↗

Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies.Semantic proximity Read ↗

A Brief Journey through Protein Misfolding in Transthyretin Amyloidosis (ATTR Amyloidosis).Semantic proximity Read ↗

Disease-Modifying Treatments for Transthyretin Amyloidosis.Semantic proximity Read ↗

Updates on hereditary transthyretin amyloidosis polyneuropathy.Semantic proximity Read ↗

Not So Rare After All: Rethinking Hereditary Transthyretin AmyloidosisSemantic proximity Read ↗

Drug and Gene Therapy for Treating Variant Transthyretin Amyloidosis (ATTRv) Neuropathy.Semantic proximity Read ↗

Hereditary transthyretin amyloidosis: a myriad of factors that influence phenotypic variability.Semantic proximity Read ↗

Transthyretin: a review from a structural perspective.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.